Literature DB >> 8117900

Regression dilution in the proportional hazards model.

M D Hughes1.   

Abstract

The problem of regression dilution arising from covariate measurement error is investigated for survival data using the proportional hazards model. The naive approach to parameter estimation is considered whereby observed covariate values are used, inappropriately, in the usual analysis instead of the underlying covariate values. A relationship between the estimated parameter in large samples and the true parameter is obtained showing that the bias does not depend on the form of the baseline hazard function when the errors are normally distributed. With high censorship, adjustment of the naive estimate by the factor 1 + lambda, where lambda is the ratio of within-person variability about an underlying mean level to the variability of these levels in the population sampled, removes the bias. As censorship increases, the adjustment required increases and when there is no censorship is markedly higher than 1 + lambda and depends also on the true risk relationship.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8117900

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  20 in total

1.  Weibull regression for lifetimes measured with error.

Authors:  C J Skinner; K Humphreys
Journal:  Lifetime Data Anal       Date:  1999       Impact factor: 1.588

2.  Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis project.

Authors:  Matthias W Lorenz; Horst Bickel; Michiel L Bots; Monique M B Breteler; Alberico L Catapano; Moise Desvarieux; Bo Hedblad; Bernhard Iglseder; Stein Harald Johnsen; Michal Juraska; Stefan Kiechl; Ellisiv B Mathiesen; Giuseppe D Norata; Liliana Grigore; Joseph Polak; Holger Poppert; Maria Rosvall; Tatjana Rundek; Ralph L Sacco; Dirk Sander; Matthias Sitzer; Helmuth Steinmetz; Eva Stensland; Johann Willeit; Jacqueline Witteman; David Yanez; Simon G Thompson
Journal:  Am Heart J       Date:  2010-05       Impact factor: 4.749

3.  A Joint Model for Prognostic Effect of Biomarker Variability on Outcomes: long-term intraocular pressure (IOP) fluctuation on the risk of developing primary open-angle glaucoma (POAG).

Authors:  Feng Gao; J Philip Miller; Stefano Miglior; Julia A Beiser; Valter Torri; Michael A Kass; Mae O Gordon
Journal:  JP J Biostat       Date:  2011-05-01

4.  Approximate nonparametric corrected-score method for joint modeling of survival and longitudinal data measured with error.

Authors:  Jean D Tapsoba; Jean de Dieu Tapsoba; Shen-Ming Lee; C Y Wang
Journal:  Biom J       Date:  2011-07       Impact factor: 2.207

5.  Covariate measurement error correction methods in mediation analysis with failure time data.

Authors:  Shanshan Zhao; Ross L Prentice
Journal:  Biometrics       Date:  2014-08-19       Impact factor: 2.571

6.  Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks.

Authors:  Hao-Min Cheng; Shao-Yuan Chuang; Shih-Hsien Sung; Wen-Chung Yu; Alan Pearson; Edward G Lakatta; Wen-Harn Pan; Chen-Huan Chen
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

7.  Cox regression with dependent error in covariates.

Authors:  Yijian Huang; Ching-Yun Wang
Journal:  Biometrics       Date:  2017-07-06       Impact factor: 2.571

8.  A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.

Authors:  Feng Gao; J Philip Miller; Chengjie Xiong; Julia A Beiser; Mae Gordon
Journal:  Stat Methods Appt       Date:  2011-03-01

9.  Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies.

Authors: 
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

10.  What can we learn from a decade of database audits? The Duke Clinical Research Institute experience, 1997--2006.

Authors:  Reza Rostami; Meredith Nahm; Carl F Pieper
Journal:  Clin Trials       Date:  2009-04       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.